InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-01 · accession 0001209191-22-059830 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-05 2022-12-01 WGS Feeley Kevin CFO M - OptEx — +23.7K 23.7K New —
D 2022-12-05 2022-12-02 WGS Feeley Kevin CFO S - Sale+OE $0.4 -8,465 15.2K -36% -$3,386
D 2022-12-05 2022-12-01 WGS Feeley Kevin CFO M - OptEx $0.00 -23.7K 355.1K -6% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-12-01 M A 23,674 — 23,674 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Common Class A Common Stock 2022-12-02 S D 8,465 $0.4 15,209 D — —
3 Derivative Restricted Stock Unit 2022-12-01 M D 23,674 $0.00 355,113 D — · — to — 23,674 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vested in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date